Handbook of experimental pharmacology "dendritic cells": The use of dexamethasone in the induction of tolerogenic DCs

Handbook of Experimental Pharmacology

Volumn 188, Issue , 2009, Pages 233-249

  Van Kooten, Cees ^a   Stax, Annelein S ^b   Woltman, Andrea M ^b   Gelderman, Kyra A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; B7 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD34 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COLECALCIFEROL; COMPLEMENT COMPONENT C1Q; CORTISONE; DEXAMETHASONE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTRAXIN 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL INTERACTION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY DISEASE; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TRANSPLANTATION TOLERANCE; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CELL SHAPE; DRUG EFFECT; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PHENOTYPE; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNITY; CELL SHAPE; CYTOKINES; DENDRITIC CELLS; DEXAMETHASONE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; INFLAMMATION; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 60549117005     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-71029-5_11     Document Type: Review

References (90)

1. AbeM, Thomson AW(2006) Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin Immunol 118:300-306
2. Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127-134
3. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252
4. Bharadwaj U, Zhang R, Yang H, Li M, Doan LX, Chen C, Yao Q (2005) Effects of cyclophilin A on myeloblastic cell line KG-1 derived dendritic like cells (DLC) through p38 MAP kinase activation. J Surg Res 127:29-38
5. Boor PP,Metselaar HJ,Mancham S, Tilanus HW, Kusters JG, Kwekkeboom J (2006) Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells. Am J Transplant 6:2332-2341
6. Bosma BM, Metselaar HJ, Tra WM, Mancham S, Kuipers EJ, Tilanus HW, Kwekkeboom J (2007) Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients. Clin Exp Immunol 149:525-534
7. Brokaw JJ, White GW, Baluk P, Anderson GP, Umemoto EY, McDonald DM (1998) Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol 19:598-605
8. Bros M, Jahrling F, Renzing A, Wiechmann N, Dang NA, Sutter A, Ross R, Knop J, Sudowe S, Reske-Kunz AB (2007) A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 109:3820-3829
9. Canning MO, Grotenhuis K, De Wit HJ, Drexhage HA (2000) Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur J Endocrinol 143:687-695
10. Castellano G,Woltman AM, Nauta AJ, Roos A, Trouw LA, Seelen MA, Schena FP, Daha MR, van Kooten C (2004) Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103:3813-3820
11. Cohen N, Mouly E, Hamdi H, Maillot MC, Pallardy M, Godot V, Capel F, Balian A, Naveau S, Galanaud P, Lemoine FM, Emilie D (2006) GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107:2037-2044
12. de Jong EC, Vieira PL, Kalinski P, Kapsenberg ML (1999) Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 66:201-204
13. Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A (2006) Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 79:797-802
14. Duperrier K, Velten FW, Bohlender J, Demory A, Metharom P, Goerdt S (2005) Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol Immunol 42:1531-1540
15. Emmer PM, van d, V, Adema GJ, Hilbrands LB (2006) Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 81:1451-1459
16. Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA (1999) Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48:2300-2308
17. Freeman L, Hewison M, Hughes SV, Evans KN, Hardie D, Means TK, Chakraverty R (2005) Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood 106:2042-2049
18. +, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659-665
19. Garrovillo M, Ali A, Depaz HA, Gopinathan R, Oluwole OO, Hardy MA, Oluwole SF (2001) Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant 1:129-137
20. Giles KM, Ross K, Rossi AG, Hotchin NA, Haslett C, Dransfield I (2001) Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J Immunol 167:976-986
21. Grohmann U, Volpi C, Fallarino F, Bozza S, Bianchi R, Vacca C, Orabona C, Belladonna ML, Ayroldi E, Nocentini G, Boon L, Bistoni F, Fioretti MC, Romani L, Riccardi C, Puccetti P (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13:579-586
22. Hackstein H, Renner FC, Bohnert A, Nockher A, Frommer T, Bein G, Weimer R (2005) Dendritic cell deficiency in the blood of kidney transplant patients on long-term immunosuppression: results of a prospective matched-cohort study. Am J Transplant 5:2945-2953
23. Hackstein H, Thomson AW (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4:24-35
24. Hesselink DA, Vaessen LM, Hop WC, Schoordijk W, Ijzermans JN, Baan CC, Weimar W (2005) The effects of renal transplantation on circulating dendritic cells. Clin Exp Immunol 140: 384-393
25. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Burger A (2004) Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol 122:673-684
26. Hsu NC, Chung CY, Horng HC, Chang CS (2004) Corticosteroid administration depresses circulating dendritic cells in ITP patients. Platelets 15:451-454
27. Kim KD, Choe YK, Choe IS, Lim JS (2001) Inhibition of glucocorticoid-mediated, caspaseindependent dendritic cell death by CD40 activation. J Leukoc Biol 69:426-434
28. Kitajima T, Ariizumi K, Bergstresser PR, Takashima A (1996) A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line. J Clin Invest 98:142-147
29. Koopman G, Dalgleish AG, Bhogal BS, Haaksma AG, Heeney JL (2001) Changes in dendritic cell subsets in the lymph nodes of rhesus macaques after application of glucocorticoids. Hum Immunol 62:208-214
30. Lan YY, Wang Z, Raimondi G, Wu W, Colvin BL, de CA, Thomson AW (2006) "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol 177:5868-5877
31. Li M, Zhang X, Zheng X, Lian D, Zhang ZX, Ge W, Yang J, Vladau C, Suzuki M, Chen D, Zhong R, Garcia B, Jevnikar AM, MinWP (2007) Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol 178:5480-5487
32. Ling Y, Cao X, Yu Z, Ruan C (2007) Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Haematol 79:310-316
33. Link H, Huang YM, Masterman T, Xiao BG (2001) Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis. J Neuroimmunol 114:1-7
34. Ludewig B, Junt T, Hengartner H, Zinkernagel RM(2001) Dendritic cells in autoimmune diseases. Curr Opin Immunol 13:657-662
35. Lutz MB, Suri RM, Niimi M, Ogilvie AL, Kukutsch NA, Rossner S, Schuler G, Austyn JM (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813-1822
36. Macedo C, Popescu I, bu-Elmagd K, Reyes J, Shapiro R, Zeevi A, Berghaus JM, Wang LF, Lu L, Thomson AW, Storkus WJ, Fung JJ, Metes D (2005) Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation 79:451-459
37. Mainali ES, Tew JG (2004) Dexamethasone selectively inhibits differentiation of cord blood stem cell derived-dendritic cell (DC) precursors into immature DCs. Cell Immunol 232:127-136
38. Manome H, Aiba S, Singh S, Yoshino Y, Tagami H (2000) Dexamethasone and cyclosporin A affect the maturation of monocyte-derived dendritic cells differently. Int Arch Allergy Immunol 122:76-84
39. Matasic R, Dietz AB, Vuk-Pavlovic S (1999) Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 66:909-914
40. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A (2002) Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol 169:3555-3564
41. Matyszak MK, Citterio S, Rescigno M, Ricciardi-Castagnoli P (2000) Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 30:1233-1242
42. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW (2005) Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5:314-322
43. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW (2003) Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3:689-696
44. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195:15-21
45. Mirenda V, Berton I, Read J, Cook T, Smith J, Dorling A, Lechler RI (2004) Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J Am Soc Nephrol 15:987-997
46. Morelli AE, Thomson AW(2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7:610-621
47. Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J, Leo O (1995) Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 25:2818-2824
48. Mozo L, Suarez A, Gutierrez C (2004) Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin Exp Allergy 34:406-412
49. Oluwole OO, Depaz HA, Gopinathan R, Ali A, Garrovillo M, Jin MX, Hardy MA, Oluwole SF (2001) Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 50:1546-1552
50. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA (2002) Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16:257-270
51. Peche H, Trinite B, Martinet B, Cuturi MC (2005) Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 5:255-267
52. Piemonti L, Monti P, Allavena P, Leone BE, Caputo A, Di C, V (1999a) Glucocorticoids increase the endocytic activity of human dendritic cells. Int Immunol 11:1519-1526
53. Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone BE, Socci C, Di C, V (1999b) Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473-6481
54. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW (1995) Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366-1370
55. Rea D, van Kooten C, VanMeijgaarden KE, Melief CJM, Offringa R (2000) Glucocorticoids transformCD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen presenting cells that secrete IL-10. Blood 95:3162-3167
56. Reis E, Sousa C (2006) Dendritic cells in a mature age. Nat Rev Immunol 6:476-483
57. Reis ES, Barbuto JA, Isaac L (2006) Human monocyte-derived dendritic cells are a source of several complement proteins. Inflamm Res 55:179-184
58. Roelen DL, Schuurhuis DH, van den Boogaardt DE, Koekkoek K, van Miert PP, van Schip JJ, Laban S, Rea D, Melief CJ, Offringa R, Ossendorp F, Claas FH (2003) Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 76:1608-1615
59. Rozkova D, Horvath R, Bartunkova J, Spisek R (2006) Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol 120:260-271
60. Santegoets SJ, Masterson AJ, van der Sluis PC, Lougheed SM, Fluitsma DM, Van den Eertwegh AJ, Pinedo HM, Scheper RJ, de Gruijl TD (2006) A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor. J Leukoc Biol 80:1337-1344
61. Sebelin K, Schulzki A, Kloetzel PM, Dorken B, Pezzutto A, Subklewe M (2006) Impairment of circulating myeloid dendritic cells in immunosuppressed renal/pancreas transplant recipients. Transplantation 82:779-787
62. Shinomiya M, Fazle Akbar SM, Shinomiya H, Onji M (1999) Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 117:38-43
63. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419-426
64. Sternberg EM (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6:318-328
65. Sternberg EM, Chrousos GP, Wilder RL, Gold PW (1992) The stress response and the regulation of inflammatory disease. Ann Intern Med 117:854-866
66. Stock P, Akbari O, DeKruyff RH, Umetsu DT (2005) Respiratory tolerance is inhibited by the administration of corticosteroids. J Immunol 175:7380-7387
67. Suda T, Chida K, Matsuda H, Hashizume H, Ide K, Yokomura K, Suzuki K, Kuwata H, Miwa S, Nakano H, Fujisawa T, Enomoto N, Matsushita A, Nakamura H (2003) High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells. J Allergy Clin Immunol 112:1237-1239
68. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, Beutelspacher SC, Foxwell BM, Lombardi G, George AJ (2005) Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 174:7633-7644
69. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS (2007) CD4 + CD25 + Foxp3+ regulatory T cells induce alternative activation of human monocytes/ macrophages. Proc Natl Acad Sci U S A 104:19446-19451
70. van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE (2007) Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 179:1506-1515
71. van Vliet SJ, Gringhuis SI, Geijtenbeek TB, van Kooyk Y (2006a) Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol 7:1200-1208
72. van Vliet SJ, van Liempt E, Geijtenbeek TB, van Kooyk Y (2006b) Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. Immunobiology 211:577-585
73. Vanclee A, Schouten HC, Bos GM (2006) Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells. Transpl Immunol 16:8-13
74. Vanderheyde N, Verhasselt V, Goldman M, Willems F (1999) Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67:1342-1347
75. Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B (2003) Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol 3:345-357
76. Vendetti S, Chai JG, Dyson J, Simpson E, Lombardi G, Lechler R (2000) Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol 165:1175-1181
77. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC (1998) Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161:5245-5251
78. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, De Kloet ER, Nagelkerken L (1998) Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91:4255- 4264
79. Vital AL, Goncalo M, Cruz MT, Figueiredo A, Duarte CB, Lopes MC (2003) Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kappaB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line. Mediators Inflamm 12:71-78
80. Vizzardelli C, Pavelka N, Luchini A, Zanoni I, Bendickson L, Pelizzola M, Beretta O, Foti M, Granucci F, Nilsen-Hamilton M, Ricciardi-Castagnoli P (2006) Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur J Immunol 36:1504-1515
81. Vulcano M, Struyf S, Scapini P, Cassatella M, Bernasconi S, Bonecchi R, Calleri A, Penna G, Adorini L, Luini W, Mantovani A, Van DJ, Sozzani S (2003) Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 170:3843-3849
82. Wilckens T, De Rijk R (1997) Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 18:418-424
83. Woltman AM, De Fijter JW, Kamerling SW, Paul LC, Daha MR, van Kooten C (2000) The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30:1807-1812
84. Woltman AM, De Fijter JW, Zuidwijk K, Vlug AG, Bajema IM, Van der Kooij SW, van Ham V, van Kooten C (2007) Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int 71:1001-1008
85. Woltman AM, Massacrier C, De Fijter JW, Caux C, van Kooten C (2002) Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 168:6181-6188
86. Woltman AM, Van der Kooij SW, De Fijter JW, van Kooten C (2006) Maturation-resistant dendritic cells induce hyporesponsiveness in alloreactive CD45RA+ and CD45RO+ T-cell populations. Am J Transplant 6:2580-2591
87. Woltman AM, van Kooten C (2003) Functional modulation of dendritic cells to suppress adaptive immune responses. J Leukoc Biol 73:428-441
88. Xia CQ, Peng R, Beato F, Clare-Salzler MJ (2005) Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 62:45-54
89. Xing N, L Maldonado ML, Bachman LA, McKean DJ, Kumar R, Griffin MD (2002) Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 297:645-652
90. Zhang TY, Ding X, Daynes RA (2005) The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879-889